The Anesthesia CO2 Absorbent Market was valued at USD 95.62 million in 2025 and is projected to reach USD 194.76 million by 2033, growing at a CAGR of 9.30% from 2026 to 2033. The market is witnessing steady growth driven by the increasing volume of surgical procedures worldwide, rising adoption of low-flow anesthesia techniques, and growing emphasis on patient safety and operational efficiency in healthcare facilities.

The growing prevalence of chronic diseases requiring surgical intervention, along with expanding healthcare infrastructure and rising investments in advanced anesthesia delivery systems, is encouraging hospitals and ambulatory surgical centers to adopt high-performance CO2 absorbents. In addition, the shift toward environmentally safer and dust-free absorbent formulations, coupled with technological advancements aimed at reducing toxic byproduct formation during anesthesia, is further supporting market expansion across developed and emerging healthcare markets.